During the past decade, Kern Research Inc. conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kern Research Inc." #1 sponsor was "Concert Pharmaceuticals" with 3 trials, followed by "Optinose US Inc." with 2 trials sponsored, "ALK-Abelló A/S" with 1 trials sponsored, "Bond Avillion 2 Development LP" with 1 trials sponsored and "Bosch Healthcare Solutions GmbH" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kern Research Inc." #1 collaborator was "Global BioClinical" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Kern Research Inc." are "Alopecia Areata" (3 trials), "Asthma" (3 trials), "Chronic Spontaneous Urticaria" (2 trials), "Allergic Rhinitis Due to Dermatophagoides Farinae" (1 trials) and "Allergic Rhinitis Due to Dermatophagoides Pteronyssinus" (1 trials). Many other conditions were trialed in "Kern Research Inc." in a lesser frequency.

Most popular intervention types in "Kern Research Inc." are "Drug" (10 trials), "Biological" (2 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "CTP-543" (2 trials), "OPN-375" (2 trials), "AS MDI" (1 trials) and "BDA MDI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kern Research Inc." are 12 trials for "All" genders.

Currently, there are NaN active trials in "Kern Research Inc.". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Kern Research Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kern Research Inc., 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".